Dow Up0.08% Nasdaq Down0.21%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
116.68 Down 1.56(1.32%) 1:07PM EDT - Nasdaq Real Time Price
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Avg. Estimate0.630.863.435.12
No. of Analysts6.006.006.006.00
Low Estimate0.360.652.954.97
High Estimate0.930.953.905.35
Year Ago EPS1.810.563.373.43
Revenue EstCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Avg. Estimate24.82M29.99M118.67M162.73M
No. of Analysts6676
Low Estimate18.35M27.70M114.02M156.17M
High Estimate27.00M33.80M129.15M180.00M
Year Ago Sales18.42M17.70M71.91M118.67M
Sales Growth (year/est)34.80%69.40%65.00%37.10%
Earnings HistoryJun 15Sep 15Dec 15Mar 16
EPS Est0.400.420.650.67
EPS Actual1.810.560.660.97
Difference1.410.140.010.30
Surprise %352.50%33.30%1.50%44.80%
EPS TrendsCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Current Estimate0.630.863.435.12
7 Days Ago0.740.843.375.10
30 Days Ago0.750.833.355.09
60 Days Ago0.770.813.305.07
90 Days Ago0.690.863.415.16
EPS RevisionsCurrent Qtr.
Jun 16
Next Qtr.
Sep 16
Current Year
Dec 16
Next Year
Dec 17
Up Last 7 Days0232
Up Last 30 Days1333
Down Last 30 Days3110
Down Last 90 DaysN/AN/AN/AN/A
Growth EstLGNDIndustrySectorS&P 500
Current Qtr.-65.20%44.20%-98.40%8.20%
Next Qtr.53.60%873.00%N/A14.00%
This Year1.80%35.60%81.80%0.50%
Next Year49.30%31.50%32.70%12.80%
Past 5 Years (per annum)41.55%N/AN/AN/A
Next 5 Years (per annum)46.03%17.32%18.15%6.88%
Price/Earnings (avg. for comparison categories)34.47-6.991.5316.04
PEG Ratio (avg. for comparison categories)0.751.641.07-2.45
Currency in USD.